Dietary krill oil supplementation reduces hepatic steatosis, glycemia, and hypercholesterolemia in high-fat-fed mice

Journal of Agricultural and Food Chemistry

Volumn 57, Issue 19, 2009, Pages 9339-9345

  Tandy, Sally ^a   Chung, Rosanna W S ^a   Elaine, W A T ^a   Berge, Alvin Kamili Kjetil ^a   Griinari, Mikko ^b   Cohn, Jeffrey S ^a,c  

^a HEART RESEARCH INSTITUTE   (Australia)

^b former employee of Aker BioMarine Antarctic AS   (Norway)

^c Clanet Oy   (Finland)

Author keywords

Cholesterol; Hepatomegaly; Hepatosteatosis; Krill oil; Liver; N 3 fatty acids; Phospholipids; Triglyceride

Indexed keywords

ADIPONECTIN; CHOLESTEROL; EDIBLE OIL; OMEGA 3 FATTY ACID;

ANIMAL; ARTICLE; BLOOD; C57BL MOUSE; CHEMISTRY; EUPHAUSIACEA; FAT INTAKE; FATTY LIVER; GLUCOSE BLOOD LEVEL; HYPERCHOLESTEROLEMIA; MALE; MOUSE;

ADIPONECTIN; ANIMALS; BLOOD GLUCOSE; CHOLESTEROL; DIETARY FATS; DIETARY FATS, UNSATURATED; EUPHAUSIACEA; FATTY ACIDS, OMEGA-3; FATTY LIVER; HYPERCHOLESTEROLEMIA; MALE; MICE; MICE, INBRED C57BL;

ANIMALIA; DECAPODA (CRUSTACEA); EUPHAUSIACEA; MUS;

EID: 70349904443     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf9016042     Document Type: Article

References (42)

1. Harris, W. S. n-3 fatty acids and serum lipoproteins: animal studies. Am. J. Clin. Nutr. 1991, 65, 1611S-1616S.
2. Eslick, G. D.; Howe, P. R.; Smith, C.; Priest, R.; Bensoussan, A. Benefits of fish oil supplementation in hyperlipidemia: A systematic review and meta-analysis. Int. J. Cardiol. 2009, 136, 4-16.
3. (3) Breslow, J. L. n-3 fatty acids and cardiovascular disease. Am. J. Clin. Nutr. 2006, 83, 1477S-1482S. (Pubitemid 44713088)
4. Harris, W. S.; Miller, M.; Tighe, A. P.; Davidson, M. H.; Schaefer, E. J. Omega-3 fatty acids and coronary heart disease risk: Clinical and mechanistic perspectives. Atherosclerosis 2008, 197, 12-24.
5. (5) Cleland, L. G.; James, M. J.; Proudman, S. M. The role offish oils in the treatment of rheumatoid arthritis. Drugs 2003, 63, 845-853. (Pubitemid 36543082)
6. Boudrault, C.; Bazinet, R. P.; Ma, D. W. Experimental models and mechanisms underlying the protective effects of n-3 polyunsaturated fatty acids in Alzheimer's disease. J. Nutr. Biochem. 2009, 20, 1-10.
7. Fedor, D.; Kelley, D. S. Prevention of insulin resistance by n-3 polyunsaturated fatty acids. Curr. Opin. Clin. Nutr. Metab. Care 2009, 12, 138-146.
8. (8) Cansell, M.; Nacka, F.; Combe, N. Marine lipid-based liposomes increase in vivo FA bioavailability. Lipids 2003, 38, 551-559. (Pubitemid 36760244)
9. 13C]DHA in phosphatidylcholine. J. Lipid Res. 1999, 40, 1867-1874.
10. (10) Cohn, J. S.; Wat, E.; Kamili, A.; Tandy, S. Dietary phospholipids, hepatic lipid metabolism and cardiovascular disease. Curr. Opin. Lipidol. 2008, 19, 257-262. (Pubitemid 351653563)
11. Wat, E.; Tandy, S.; Kapera, E.; Kamili, A.; Chung, R. W.; Brown, A.; Rowney, M.; Cohn, J. S. Dietary phospholipid-rich dairy milk extract reduces hepatomegaly, hepatic steatosis and hyperlipidemia in mice fed a high-fat diet. Atherosclerosis 2009, 205, 144-150.
12. (12) Naito, Y.; Uchiyama, K.; Aoi, W.; Hasegawa, G.; Nakamura, N.; Yoshida, N.; Maoka, T.; Takahashi, J.; Yoshikawa, T. Prevention of diabetic nephropathy by treatment with astaxanthin in diabetic db/ db mice. Biofactors 2004, 20, 49-59. (Pubitemid 38586209)
13. (13) Hussein, G.; Nakagawa, T.; Goto, H.; Shimada, Y.; Matsumoto, K.; Sankawa, U.; Watanabe, H. Astaxanthin ameliorates features of metabolic syndrome in SHR/NDmcr-cp. Life Sci. 2007, 80, 522-529. (Pubitemid 46038324)
14. (14) Ikeuchi, M.; Koyama, T.; Takahashi, J.; Yazawa, K. Effects of astaxanthin in obese mice fed a high-fat diet. Biosci., Biotechnol, Biochem. 2007, 71, 893-899. (Pubitemid 46650940)
15. (15) Sampalis, F.; Bunea, R.; Pelland, M. F.; Kowalski, O.; Duguet, N.; Dupuis, S. Evaluation of the effects of Neptune Krill Oil on the management of premenstrual syndrome and dysmenorrhea. Altern. Med. Rev. 2003, 8, 171-179. (Pubitemid 36676184)
16. (16) Bunea, R.; El Farrah, K.; Deutsch, L. Evaluation of the effects of Neptune Krill Oil on the clinical course of hyperlipidemia. Altern. Med. Rev. 2004, 9, 420-428. (Pubitemid 40066715)
17. (17) Deutsch, L. Evaluation of the effect of Neptune Krill Oil on chronic inflammation and arthritic symptoms. J. Am. Coll. Nutr. 2007, 26, 39-48. (Pubitemid 46411395)
18. Kris-Etherton, P. M.; Taylor, D. S.; Yu-Poth, S.; Huth, P.; Moriarty, K.; Fishell, V.; Hargrove, R. L.; Zhao, G.; Etherton, T. D. Polyunsaturated fatty acids in the food chain in the United States. Am. J. Clin. Nutr. 2000, 71, 179S-188S.
19. (19) Harris, W. S. n-3 fatty acids and serum lipoproteins: animal studies. Am. J. Clin. Nutr. 1997, 65, 1611S-1616S. (Pubitemid 27187955)
20. Bligh, E. G.; Dyer, W. J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 1959, 37, 911-917.
21. van Vlijmen, B. J.; Mensink, R. P.; van't Hof, H. B.; Offermans, R. F; Hofker, M. H.; Havekes, L. M. Effects of dietary fish oil on serum lipids and VLDL kinetics in hyperlipidemic apolipoprotein E*3Leiden transgenic mice. J. Lipid Res. 1998, 39, 1181-1188.
22. (22) Kim, H. J.; Takahashi, M.; Ezaki, O. Fish oil feeding decreases mature sterol regulatory element-binding protein 1 (SREBP-1) by down-regulation of SREBP-1c mRNA in mouse liver. A possible mechanism for down-regulation of lipogenic enzyme mRNAs. J. Biol. Chem. 1999, 274, 25892-25898. (Pubitemid 129530770)
23. (23) Sekiya, M.; Yahagi, N.; Matsuzaka, T.; Najima, Y.; Nakakuki, M.; Nagai, R.; Ishibashi, S.; Osuga, J.; Yamada, N.; Shimano, H. Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression. Hepatology 2003, 38,1529-1539. (Pubitemid 37466979)
24. Ide, T. Interaction offish oil and conjugated linoleic acid in affecting hepatic activity of lipogenic enzymes and gene expression in liver and adipose tissue. Diabetes 2005, 54, 412-423.
25. Qi, K.; Fan, C.; Jiang, J.; Zhu, H.; Jiao, H.; Meng, Q.; Deckelbaum, R. J. Omega-3 fatty acid containing diets decrease plasma triglyceride concentrations in mice by reducing endogenous triglyceride synthesis and enhancing the blood clearance of triglyceride-rich particles. Clin. Nutr. 2008, 27, 424-430.
26. (26) Neschen, S.; Morino, K.; Dong, J.; Wang-Fischer, Y.; Cline, G. W.; Romanelli, A. J.; Rossbacher, J. C.; Moore, I. K.; Regittnig, W.; Munoz, D. S.; Kim, J. H.; Shulman, G. I. n-3 Fatty acids preserve insulin sensitivity in vivo in a peroxisome proliferator-activated receptor-alpha-dependent manner. Diabetes 2007, 56, 1034-1041. (Pubitemid 46525082)
27. González-Périz, A.; Horrillo, R.; Ferré, N.; Gronert, K.; Dong, B.; Morán-Salvador, E.; Titos, E.; Martínez-Clemente, M.; López-Parra, M.; Arroyo, V.; Ciària, J. Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. FASEB J. 2009, DOI: 10.1096/ fj.08-125674.
28. (28) González-Périz, A.; Planagumá, A.; Gronert, K.; Miquel, R; LópezParra, M.; Titos, E.; Horrillo, R.; Ferré, N.; Deulofeu, R.; Arroyo, V.; Rodés, J.; Ciária, J. Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA. FASEB J. 2006, 20, 2537-2539. (Pubitemid 44953772)
29. (29) Schmöcker, C.; Weylandt, K. H.; Kahlke, L.; Wang, J.; Lobeck, H.; Tiegs, G.; Berg, T.; Kang, J. X. Omega-3 fatty acids alleviate chemically induced acute hepatitis by suppression of cytokines. Hepatology 2007, 45, 864-869. (Pubitemid 46631554)
30. (30) Todoric, J; Löffler, M.; Huber, J.; Bilban, M.; Reimers, M.; Kadl, A.; Zeyda, M.; Waldhäusl, W.; Stulnig, T. M. Adipose tissue inflammation induced by high-fat diet in obese diabetic mice is prevented by n-3 polyunsaturated fatty acids. Diahetologia 2006, 49, 2109-2119. (Pubitemid 44168479)
31. Saraswathi, V.; Gao, L.; Morrow, J. D.; Chait, A.; Niswender, K. D.; Hasty, A. H. Fish oil increases cholesterol storage in white adipose tissue with concomitant decreases in inflammation, hepatic steatosis, and atherosclerosis in mice. J. Nutr. 2007, 137, 1776-1782.
32. (32) Huber, J.; Löffler, M.; Bilban, M.; Reimers, M.; Kadi, A.; Todoric, J.; Zeyda, M.; Geyeregger, R.; Schreiner, M.; Weichhart, T.; Leitinger, N.; Waldhäusl, W.; Stulnig, T. M. Prevention of highfat diet-induced adipose tissue remodeling in obese diabetic mice by n-3 polyunsaturated fatty acids. Int. J. Obes. (London) 2007, 31, 1004-1013. (Pubitemid 46844776)
33. (33) Jump, D. B.; Botolin, D.; Wang, Y.; Xu, J.; Christian, B.; Demeure, O. Fatty acid regulation of hepatic gene transcription. J. Nutr. 2005, 135, 2503-2506. (Pubitemid 43156586)
34. (34) Nakatani, T.; Kim, H. J.; Kaburagi, Y.; Yasuda, K.; Ezaki, O. A low fish oil inhibits SREBP-1 proteolytic cascade, while a high-fish-oil feeding decreases SREBP-1 m RNA in mice liver: Relationship to anti-obesity. J. Lipid Res. 2003, 44, 369-379. (Pubitemid 37287780)
35. Goldberg, R. B.; Sabharwal, A. K. Fish oil in the treatment of dyslipidemia. Curr. Opin. Endocrinol., Diabetes Obes. 2008, 15, 167-174.
36. Davidson, M. H. Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids. Am. J. Cardiol. 2006, 98, 27i-33i.
37. (37) Flachs, P.; Mohamed-Ali, V.; Horakova, O.; Rossmeisl, M.; Hosseinzadeh-Attar, M. J.; Hensler, M.; Ruzickova, J.; Kopecky, J. Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet. Diahetologia 2006, 49, 394-397. (Pubitemid 43185410)
38. (38) Itoh, M.; Suganami, T.; Satoh, N.; Tanimoto-Koyama, K.; Yuan, X.; Tanaka, M.; Kawano, H.; Yano, T.; Aoe, S.; Takeya, M.; Shimatsu, A.; Kuzuya, H.; Kamei, Y.; Ogawa, Y. Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects. Arterioseler., Thromb., Vase. Biol. 2007, 27, 1918-1925. (Pubitemid 47315642)
39. (39) Kadowaki, T.; Yamauchi, T.; Kubota, N.; Hara, K.; Ueki, K.; Tobe, K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest. 2006, 116, 1784-1792. (Pubitemid 44033298)
40. Lu, J. Y.; Huang, K. C.; Chang, L. C.; Huang, Y. S.; Chi, Y. C.; Su, T. C.; Chen, C. L.; Yang, W. S. Adiponectin: A biomarker of obesityinduced insulin resistance in adipose tissue and beyond. J. Biomed. Sci. 2008, 15, 565-576.
41. Manco, M.; Bottazzo, G.; DeVito, R.; Marcellini, M.; Mingrone, G.; Nobili, V. Nonalcoholic fatty liver disease in children. J. Am. Coll. Nutr. 2008, 27, 667-676.
42. (42) Amarapurkar, D.; Kamani, P.; Patel, N.; Gupte, P.; Kumar, P.; Agal, S.; Baijal, R.; LaIa, S.; Chaudhary, D.; Deshpande, A. Prevalence of non-alcoholic fatty liver disease: Population based study. Ann. Hepatol. 2007, 6, 161-163. (Pubitemid 350277193)